Dr. Lutz Angerer, LL.M. (University of Virginia)
Lutz Angerer is an experienced down-to-earth M&A partner who is focused on pushing your M&A transactions over the finishing line, in particular in the life sciences industry where he has a wealth of knowledge and experience. He can also help you with your stock corporation law, corporate governance and corporate compliance issues and stands firm as a rock by your side when the going gets tough and you are involved in corporate litigation. Corporate reorganizations, Equity Capital Markets transactions, capital markets law and general corporate law are also within his area of knowledge.
Lutz works out of our Munich office but is well connected in our global network. He is not only the head of our German Practice Group Corporate/M&A and of our German Corporate Compliance Team, but is also co-leader of our Global Life Sciences Transactions Team and member of our Global Life Sciences Industry Sector Team. Lutz' first case in 1993 was a life sciences case and he has worked for life sciences clients ever since. His deep and long-standing life sciences industry experience is instrumental for closing your life sciences deals successfully and the reason why he was awarded the title 'Life Sciences Star' by the Legal Media Group.
Lutz started his career as a research assistant to renowned corporate law Professor Karsten Schmidt at the University of Hamburg. During this time, Lutz became a cutting-edge corporate lawyer. He is bi-cultural because he lived for more than one year in the US, has a Master of Laws from the University of Virginia and many of his clients are also from the US. Lutz is a member of the German-American Lawyers Association and of the German Corporate Law Association and publishes regularly. Among other achievements he is co-editor and co-author of the first commentary on the German Takeover Act as well as co-author of the handbook Transatlantic Mergers and Acquisitions.
Life Sciences Europe Star for Finance and Transactional
Lutz Angerer is according to one of his clients "very diligent and pleasant to deal with".
Advising Baxter International Inc. on the disposal of its legacy continuous renal replacement therapy business to Nikkiso by way of an asset deal in 29 countries.
Advising Delticom AG on its IPO and on the acquisition of Tirendo group.
Advising Merck & Co., Inc. on its worldwide license agreement with AiCuris GmbH & Co. KG regarding AiCuris’s HCMV portfolio.
Advising Merck & Co., Inc. on its sale of Essex Pharma Development GmbH to Adcuram Pharma Holding GmbH.
Advising Merck & Co., Inc. on the integration of the Schering-Plough group into the Merck group in Germany.
Advising PerkinElmer, Inc. on its acquisition of chemagen Biopolymer-Technologie AG and other M&A transactions.
Advising Drägerwerk AG & Co. KGaA on its €105m IPO of ordinary shares.
Advising SCM Microsystems, Inc. on its acquisition of Bluehill ID AG by way of a public takeover offer against issuance of shares in SCM Microsystems, Inc.
Advising ZOLL Medical Corporation on the acquisition of the assets of Lifebridge Medizintechnik AG.
Advising Funding Circle Holding Ltd. on its acquisition of Zencap group from Rocket Internet and others.
Frequently recommended for corporate law
Corporate solicitors, Germany
Latest thinking and events
Hogan Lovells Events
17 November 2015
Hogan Lovells Events
[Seminar]Strategic considerations for effective, profitable and successful M&A and licensing in Europe
01 December 2014